evogene.com (EVGN) - Rasio tanggungan utang jangka dawa marang modal

Long-term credit leverage demonstrates the financial stability of Evogene Ltd. (EVGN), while 0.00 records the magnitude of this parameter. Evogene Ltd. (EVGN) operates an AI-driven computational biology system, accelerating the discovery of medical and agricultural solutions. The CPB platform creates data network effects, increasing switching costs for partners. In terms of ecology, the business minimizes chemical field tests by adhering to server virtualization standards.

Analyzing the long-term sustainability of Evogene Ltd. requires an assessment of its debt structure. The long-term debt-to-equity ratio compares credit obligations exceeding one year against the market value of assets. This metric reveals the business's dependence on external financing and the associated default risk. For this AI-platform developer, low leverage confirms development autonomy driven by patent licenses. This ensures financial stability while scaling biological innovations.